Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.52
-0.13 (-0.51%)
At close: Jan 20, 2026, 4:00 PM EST
25.52
0.00 (0.00%)
After-hours: Jan 20, 2026, 6:05 PM EST
Pfizer Stock Forecast
Stock Price Forecast
The 11 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $27.18, which forecasts a 6.50% increase in the stock price over the next year. The lowest target is $24 and the highest is $35.
Price Target: $27.18 (+6.50%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 1 | 0 | 0 | 0 |
| Hold | 8 | 8 | 8 | 7 | 9 | 10 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 12 | 9 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Initiates $25 | Hold | Initiates | $25 | -2.04% | Jan 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $27 | Hold | Maintains | $28 → $27 | +5.80% | Dec 17, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +9.72% | Dec 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $28 | Hold | Maintains | $32 → $28 | +9.72% | Dec 12, 2025 |
| Citigroup | Citigroup | Hold Initiates $26 | Hold | Initiates | $26 | +1.88% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
62.77B
from 63.63B
Decreased by -1.35%
Revenue Next Year
61.70B
from 62.77B
Decreased by -1.70%
EPS This Year
3.15
from 1.41
Increased by 123.21%
EPS Next Year
3.04
from 3.15
Decreased by -3.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 66.6B | 65.9B | ||||
| Avg | 62.8B | 61.7B | ||||
| Low | 59.9B | 58.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.7% | 5.0% | ||||
| Avg | -1.4% | -1.7% | ||||
| Low | -5.8% | -6.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.40 | 3.47 | ||||
| Avg | 3.15 | 3.04 | ||||
| Low | 2.94 | 2.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 140.9% | 9.9% | ||||
| Avg | 123.2% | -3.6% | ||||
| Low | 108.2% | -12.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.